Skip to main content
. 2020 May 8;10(5):907. doi: 10.3390/nano10050907

Figure 9.

Figure 9

Haematoxylin and eosin representative histological sections of control liver (a), liver at 24 h post-injection of PEGylated CF@MF NPs (b), control kidney (c), and kidney at 24 h post-injection of PEGylated CF@MF NPs (d).